Oracle Investment Management Inc: 13F holdings, Q4 2025
Hedge fund · SEC EDGAR filings (CIK 1012622) · Explore on the interactive board
Oracle Investment Management Inc disclosed 17 US equity positions worth $152.6m in its Q4 2025 13F filing (holdings as of December 31, 2025, filed February 18, 2026). Its largest position is WGS at 75.4% of the reported book, followed by ARDX, BHVN. The top ten holdings are 98.0% of the book, and the portfolio behaves like about 2 equal-weight positions. Versus the prior filing it opened 6 new positions, added to 4, reduced 2 and exited 5. Note: this manager's most recent filing is 2 quarters behind the newest quarter on file, so these figures are history rather than current positioning.
What does Oracle Investment Management Inc own? Top holdings as of December 31, 2025
Change is measured in shares against the previous filing (Q3 2025), so price moves do not read as decisions. This quarter: 6 new, 4 added, 2 reduced, 5 exited.
| # | Stock | Sector | Weight | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|---|
| 1 | WGS GENEDX HOLDINGS CORP | Healthcare | 75.4% | $115.1m | 884,654 | -1% | reduced |
| 2 | ARDX ARDELYX INC | Healthcare | 7.2% | $10.9m | 1,872,624 | 25% | added |
| 3 | BHVN BIOHAVEN LTD | Healthcare | 5.7% | $8.7m | 772,181 | 4% | added |
| 4 | QDEL QUIDELORTHO CORP | Healthcare | 2.2% | $3.4m | 118,291 | 0% | held |
| 5 | FORIAN INC | 1.9% | $2.9m | 1,366,107 | 0% | held | |
| 6 | PSNL PERSONALIS INC | Healthcare | 1.8% | $2.7m | 339,343 | 48% | added |
| 7 | TDOC TELADOC HEALTH INC | Healthcare | 1.6% | $2.5m | 354,338 | -50% | reduced |
| 8 | TSHA TAYSHA GENE THERAPIES INC | Healthcare | 1.0% | $1.5m | 265,000 | – | new |
| 9 | CAVA CAVA GROUP INC | Consumer Cyclical | 0.7% | $1.0m | 17,100 | 0% | held |
| 10 | EWTX EDGEWISE THERAPEUTICS INC | 0.6% | $951.5k | 38,343 | – | new | |
| 11 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 0.6% | $932.0k | 100,000 | – | new | |
| 12 | ARKG ARK ETF TR | 0.4% | $564.9k | 19,500 | – | new | |
| 13 | SGMOQ SANGAMO THERAPEUTICS INC | Healthcare | 0.3% | $435.0k | 1,035,742 | 3% | added |
| 14 | BIIB BIOGEN INC | Healthcare | 0.3% | $424.5k | 2,412 | 0% | held |
| 15 | TEM TEMPUS AI INC | Healthcare | 0.3% | $384.2k | 6,507 | – | new |
| 16 | TSLA TESLA INC | Consumer Cyclical | 0.1% | $224.9k | 500 | 0% | held |
| 17 | HTZ HERTZ GLOBAL HLDGS INC | Industrials | 0.1% | $77.1k | 15,000 | – | new |
What did Oracle Investment Management Inc sell? Positions exited since the previous filing
| Stock | Prior weight | Prior value |
|---|---|---|
| PLTR PALANTIR TECHNOLOGIES INC | 43.9% | $5.4m |
| CNC CENTENE CORP DEL | 32.1% | $3.9m |
| NVAX NOVAVAX INC | 17.2% | $2.1m |
| KRANESHARES TRUST | 5.9% | $718.6k |
| BDSX BIODESIX INC | 0.9% | $113.2k |
Sector mix
| Sector | Weight |
|---|---|
| Healthcare | 95.6% |
| Consumer Cyclical | 0.8% |
| Industrials | 0.1% |
Sectors cover positions whose ticker resolved to a sector; the remainder is unclassified, not cash.
Filing history
How concentrated is Oracle Investment Management Inc's portfolio?
Across every quarter Oracle Investment Management Inc has filed, its median largest position is 61.4% of the book and its median top-ten weight is 98.6%, which WhaleCreep classifies as concentrated (the gate is a median largest position of 5%). Of 13.0 completed holding spells, the median lasted 1.0 quarters; 17.0 positions are still open and their final length is unknown.